Introduction
With the current upsurge of interest in the inositol phospholipids, now recognized as the source of second messengers in receptor-mediated Ca2+ mobilization (Michell et al., 1981; and protein kinase C activation (Nishizuka, 1984) , many investigators are encountering the subtleties of myo-inositol stereochemistry for the first time. Because of the symmetrical structure of myo-inositol, certain metabolites of the compound can exist in enantiomeric forms (nonsuperimposable mirror images). Although there are other instances of the biological formation of enantiomers, the myo-inositol example is unique in that the enantiomeric 1-phosphates do not derive from a common precursor. This is illustrated in Fig. 1 by the two major pathways of myo-inositol metabolism: the irreversible biosynthesis offree myo-inositol from glucose 6-phosphate (Eisenberg, 1967) , the source which maintains de novo the supply of free myo-inositol for the organism, and the cyclic synthesis (Agranoff et al., 1958; Paulus & Kennedy, 1960) and hydrolysis (Hawthorne et al., 1960) of phosphatidylinositol via free myo-inositol. Although myo-inositol 1- phosphate is the intermediate common to both pathways, two different forms of the compound are produced, the L enantiomer by the synthetic pathway and the D by the cyclicpathway. Ineachpathwaymyo-inositol 1-phosphate is the immediate precursor of free myo-inositol in a reaction catalysed by specific myo-inositol 1 -phosphatase (Eisenberg, 1967) . Both isomers are substrates of the enzyme, liberating myo-inositol for incorporation into phosphatidylinositol and its phosphates to maintain receptor function. Since a common product is formed it is virtually impossible to gauge the relative activities of the two pathways in vivo.
myo-Inositol l-phosphatase, however, is inhibited by Li+ ( Fig. 1 ) both in vitro (Naccarato et al., 1974; Hallcher & Sherman, 1980; Sherman et al., 1984) and in vivo (Sherman et al., 1984) and under these conditions myo-inositol 1-phosphate remains intact; by determination of the fraction of this pool composed of each isomer, Sherman et al. (1984) assessed the relative contributions of the two pathways, an illustration of the importance of stereochemical information to the understanding of a biological process. Hoffmann-Ostenhof et al. (1978) have drawn similar Although the subject of stereochemistry is vast, complex, and marked by controversy even among experts (O'Loane, 1980) , the stereochemistry and the nomenclature of myo-inositol and its congeners are governed by a few simple principles and rules. Unfortunately, textbooks and other publications codifying these rules have often been wrong (IUPAC-IUB Commission on Biochemical Nomenclature, 1977 Nomenclature, /1978 and many of the errors in structure and nomenclature found in the current literature, relating the myo-inositol phosphates to mobilization of Ca2+, stem from these misleading sources. Hawthorne (1983) has similarly commented on the confusion experienced by many authors in this field.
With a view toward simplification of these rules, Klyashchitskii et al. (1969) have proposed a system of nomenclature for asymmetric inositol derivatives, based on stereospecific numbering similar to the system used for glycerol derivatives. We concur in their proposal but until their system is given serious consideration, we shall adhere to the system presently in use. We hope in this Review to explain in a systematic way the origin and meaning of the configurational notation used in designating lipid-bound and water-soluble derivatives of myo-inositol and to illustrate these concepts with further biochemical examples. Conformation Basic to stereochemistry is the solid geometry of the particular molecules under consideration, as illustrated by Fig. 2 , which shows in perspective the conformation (three-dimensional structure) of myo-inositol. Most readers will recognize in this Figure the bonds linking carbon atoms, but many, in our experience, will not understand the spatial relationships among the carbons and the basis for placement of bonds projecting from the ring. As far as we are aware, no textbook or other published source presents a clear exposition of the origin of this construct. On the contrary, Fig. 2 is rather more often the starting point for illustration of stereochemical principles.
To explain these concepts we must refer to the more fundamental structure shown in Fig. 3 , which is' a diagram of a thermodynamically favorable arrangement of a ring of six tetrahedral carbon atoms, the basic structure of the cyclohexanehexols, commonly known as inositols. Barnett (1950) has presented an identical model a Fig. 3 . Chair form of the six-carbon ring with axial (a) and equatorial (e) bonds of cyclohexane but omitted any discussion of carboncarbon bonds or carbon-substituent bonds. These six tetrahedra reside on a common horizontal plane defined by the bases of alternating up and down members. Fig. 2 can be seen to emerge from this diagram as the broken line connecting the centres of each tetrahedron through the joined apexes; it is this line of valence bonds between adjacent carbon atoms that traces the familiar, but often vaguely described, puckered ring or stable chair form characteristic of the inositols. Valence bonds to the 12 substituent positions likewise emanate from the centre of each tetrahedron. These bonds are designated singly according to their absolute spatial relationship to the horizontal plane. A line from the centre of a tetrahedron to an apex vertically above or below the plane represents an axial bond (a); there are six of these, three pointing up from the plane and three pointing down. A line from the centre to the remaining apex represents an equatorial bond (e). There are likewise six equatorial bonds, three pointing up from the plane at about 20°and three pointing down at the same angle. Fig. 2 is thus a simplified three-dimensional version of the structure of myo-inositol based on the model of Fig. 3 . For simplicity hydrogen atoms (equatorial at C-2, all others axial) are omitted from Fig. 2 . myo-Inositol, the principal inositol in nature, is uniquely characterized among nine possible isomeric cyclohexanehexols by a single axial OH (C-2); all other OH groups ofmyo-inositol are equatorial (Posternak, 1965a; Anderson, 1971; Angyal, 1971) .
[ Fig. 3 can be converted into another thermodynamically favoured structure by rotating each tetrahedron about the line connecting it to its neighbours, so that those pointing up now point down and conversely. Axial and equatorial bonds are now interchanged. Because there is no rupture of carbon-carbon bonds in changing from one form to the other, this interconversion is referred to as a conformational change and the two forms are conformational isomers or conformers. But in the free cyclohexanehexols the most stable forms are those containing the least number of axial OH groups; the only conformer, then, of myo-inositol is depicted in Fig. 2 Although providing the groundwork for an understanding of conformational principles, Fig. 2 is cumbersome and can be replaced for an explanation of stereochemistry by Fig. 4 , the Haworth convention, in which the puckered ring of Fig. 2 is projected on to a plane, equivalent to the plane of Fig. 3 . In Fig. 4 the axial and equatorial distinction is lost since all carbon-oxygen bonds are perpendicular to the ring. Substituents are now oriented in relation to each other and designated cis for those pointing in the same direction from the plane and trans for those in the opposite direction. Thus there are two sets of cis OH groups, those at C-1, -2, -3, -5 and at C-4, -6; the two sets in turn are trans to each other.
The lack of conformational information provided by Fig. 4 must not obscure the feature that sets myo-inositol apart from its isomers, the single axial OH at C-2. Is there an easy way to discern this structure from a diagram that makes no obvious distinction between axial and equatorial groups? We can formalize a relationship between the Haworth convention (Fig. 4) and the conformational diagram (Fig. 2) (Fig. 4) is assumed to project toward the viewer and the upper edge away from the viewer, a rule often ignored but one that must be applied consistently to avoid the ambiguity implicit in a two-dimensional figure. Although myoinositol is a symmetrical molecule, and therefore not optically active, it is composed ofchemically identical but geometrically non-identical halves. A plane passed perpendicularly through the plane of Fig. 4 on a line between C-2 and C-5 divides the molecule into segments which are non-superimposable mirror images, containing optically active or chiral (right-or left-handed) secondary alcohols at C-1, -3, -4 and -6. C-1 and C-3 are of equal and opposite chirality; C-4 and C-6 are likewise paired but different from C-I and C-3. No other plane can divide myo-inositol symmetrically.
[In free myo-inositol the number 1 is assigned to the carbon nearest C-2 (axial) which on substitution gives a derivative of L configuration. Numbering proceeds clockwise on the axial OH side of the ring (IUPAC Commission on the Nomenclature of Organic Chemistry and IUPAC-IUB Commission on Biochemical Nomenclature, 1976). Carbons which on substitution with achiral (symmetrical) groups, e.g. phosphate, give optically active derivatives are assigned chirality (R or S) on the basis of sequence rules (Cahn et al., 1966) . Accordingly, C-1, C-3, C-4 and C-6 of myo-inositol are assigned the following absolute configurations: R, S, R and S, respectively, amending erroneous assignments made earlier (Cahn et al., 1956 ).]
A molecule composed of compensating chiral halves is known as a meso molecule. myo-Inositol is such a meso species; it is neither D nor Land derivatives ofmyo-inositol in which OH is replaced at the plane of symmetry are likewise meso and neither D nor L. myo-Inositol 2-phosphate is a meso derivative of myo-inositol. The use of D and L symbols with such compounds, often seen in the current literature, is meaningless. By contrast, replacement ofOH at any ofthe other four positions, C-1, -3, -4 or -6, will disturb the symmetry; the product must then be designated D or L according to which half of the molecule is involved. myo-Inositol 1-phosphate is a compound that can exist in enantiomeric (D and L) forms because it contains no plane of symmetry (Fig. 5) . From this Figure it can be seen that C-2 and C-5 are now chiral while in myo-inositol (Fig. 4) occurring disaccharide, galactinol (1-galactosyl-myoinositol), which had been shown independently to be of D configuration, they prepared an optically active myo-inositol 1-phosphate; since there was no possibility of optical inversion in this synthesis, the product was assigned D configuration. By hydrolysis of soybean phosphatidylinositol they prepared myo-inositol 1-phosphate of equal but opposite optical rotation and this isomer was assigned L configuration, confirmed by comparison with synthetic model compounds (Brown & Clark, 1963 numbered chiral carbon (C-6 in myo-inositol) specifies configuration. By viewing the C-6-C-1 edge of each form in Fig. 5 from outside the ring and placing C-6 at the top, the viewer will find that the OH at C-6 points right in the left-hand structure and left in the right-hand structure. Accordingly, the compounds were named D-and L-myo-inositol 1-phosphate, respectively. From the biogenetic standpoint this was the logical assignment, since the structure on the left was subsequently shown to originate biologically from D-glucose 6-phosphate (Eisenberg, 1967) . At about this time, however, the IUPAC Commission on the Nomenclature of Organic Chemistry and the IUPAC-IUB Commission on Biochemical Nomenclature (1968) placed the inositol nomenclature on a more rational basis by changing the convention for cyclitols to the lowest numbered chiral carbon (C-1), resulting in a reversal of configuration. For the myo-inositol 1-phosphates this can be seen in Fig. 5 by the same viewing manoeuvre as above: the phosphate group faces left in the left-hand structure and right in the right-hand structure. The compounds were now named L-and D-myo-inositol 1-phosphate, respectively. From these studies with the enantiomeric myo-inositol 1-phosphates Ballou & Pizer (1960) inferred the structure of phosphatidylinositol, which since 1968 has been assigned D configuration. A consequence of designating newly introduced substituents by the lowest number is that each enantiomer is numbered in the opposite direction, clockwise for L isomers and anticlockwise for D, referred to the side of the ring bearing the axial OH. The numbering of carbons 2 and 5, prochiral in myo-inositol, remains invariant in all derivatives of myo-inositol; C-2 identifies the position of the axial OH in these compounds.
[The configuration of chiral derivatives of myo-inositol is specified by the direction of numbering, which is found after assigning the newly substituted carbon the lowest possible number. Substitution at C-I and C-4 (Fig. 4) produces L isomers, e.g. L-myo-inositol 4-phosphate, all numbered clockwise; substitution at C-3 and C-6 produces D isomers, e.g. D-myo-inositol 1-phosphate, phosphatidyl-l-D-myo-inositol (phosphatidylinositol), and D-myo-inositol 4-phosphate, all numbered anticlockwise. D-myo-Inositol 1-phosphate is the same as L-myo-inositol 3-phosphate (and D-3 as L-1) but convention dictates the use of the lower available number.]
Stereospecificity
The myo-inositol derivatives discussed thus far (except L-myo-inositol 4-phosphate) arise as products of enzymically catalysed reactions of synthesis or breakdown. Interesting stereochemical subtleties can be discerned in these reactions in the light of principles already set out. Although myo-inositol is symmetrical, as stated earlier it is a meso compound, containing within the molecule geometrically distinct halves. Just as D and L isomers (enantiomers) are selectively attacked by asymmetric agents (e.g. enzymes) the two chirally distinct but chemically identical edges of the myo-inositol ring are in effect intramolecular D and L isomers and can similarly be recognized selectively by enzymes or other chiral agents, resulting in the formation of one or the other of a pair of enantiomeric products. Paired sites within a molecule that give rise to enantiomeric products bear an enantiotopic relationship to each other. We illustrate these points in the following discussion.
In the phosphorylation of myo-inositol by ATP, catalysed by a plant kinase, the product is L-myo-inositol 1-phosphate (Fig. 5) , clearly an attack at an enantiotopic site (Loewus et al., 1982) . This is the only system known for the direct phosphorylation of myo-inositol; in animal systems the enantiomeric myo-inositol 1-phosphates are formed by indirect routes, the L isomer from glucose 6-phosphate (Eisenberg, 1967) and the D isomer from the hydrolysis ofphosphatidylinositol (Sherman et al., 1981) . In the glycosylation of myo-inositol there is similarly stereoselective attack; the enzymic transfer of galactose from UDP-galactose to C-l of myo-inositol produces an optically active compound, L-1-O-galactosyl-myoinositol, or galactinol (Frydman & Neufeld, 1963) . In the transfer of galactose from lactose to C-6 of myo-inositol by ,-galactosidase to give D-4-galactosyl-myo-inositol (Kuo & Wells, 1978) , an isomer of galactinol, the site of attack is again geometrically determined in the substrate myo-inositol, since the paired C-4 is chemically equivalent.
In contrast with the stereospecificity displayed by each galactose transferase, the positional specificities of the two enzymes are derived from chemical differences between adjacent, non-paired, carbon atoms. The two galactosyl-myo-inositols are diastereomers, i.e. stereoisomers that are not mirror images. The two positions of substitution, C-I and C-6, bear a diastereotopic relationship to each other.
The ability of chiral agents to distinguish enantiomers in general is in fact based on the formation of diastereomeric products. The complexes formed between an enzyme and enantiomeric substrates are diastereomers; they might either be of unequal stability or unequal capability to participate in further reaction to the final product. Similarly, the attack of an enzyme on a single substrate having enantiotopic halves (e.g. myo-inositol) involves intermediate complexes that are different chemically; only one of these diastereomers is capable of further reaction, the principle underlying enzymic selection from like groups.
Phytic acid, the completely phosphorylated ester of myo-inositol, undergoes hydrolysis to diastereomeric myo-inositol pentakisphosphates by phytases (Cosgrove, 1980 ) from wheat bran and Pseudomonas. Like myo- inositol this compound is symmetrical about C-2 and C-5 and is numbered clockwise from C-1. Both phytases produce optically active pentakisphosphates, showing stereoselective attack on the molecule, but further enzyme-specific selection is determined by chemical differences between adjacent diastereotopically related groups at C-6 and C-1. The Pseudomonas enzyme is a 1-phytase, giving D-myo-inositol 1,2,4,5,6-pentakisphosphate (anticlockwise to give the lowest numbers) and the wheat bran enzyme is a 6-phytase, which yields L-myo-inositol 1,2,3,4,5-pentakisphosphate (clockwise) (Tomlinson & Ballou, 1962) . These products are diastereomers. In this example symmetry is disturbed by removal of phosphate.
Another illustration of stereoselective attack is the oxidation of myo-inositol by atmospheric oxygen catalysed by myo-inositol oxygenase, an important enzyme in plants and mammalian kidney (Charalampous, 1959) . The product of the reaction is D-glucuronic acid, with myo-inosose-l (more systematically designated 2,3,5/4,6-pentahydroxycyclohexanone) and H202 likely intermediates (Fig. 6) . The ring is cleaved between C-6 and C-1, one atom of oxygen appearing in the carboxyl group, the other in water (Moskala et al., 1981; Naber, 1983) . Biosynthesis of L-myO-inositol 1-phosphate It is interesting that in enzymic reactions ofmyo-inositol the reactive site is usually the C-6-C-1 edge. We can speculate that Nature's predilection for the myo-inositol geometry follows from the stereospecificity of the enzymic process catalysing the biosynthesis of myoinositol de novo. In this reaction D-glucose 6-phosphate, central to all carbohydrate biosynthesis, is isomerized to L-myo-inositol 1 -phosphate (Eisenberg, 1967) , a closure of the C-6-C-1 bond (Figs. I and 7 ). This reaction, together with the isomerizations leading to fructose 6-phosphate and glucose 1-phosphate, account for virtually all carbohydrates in Nature. Found in all plants and animals, L-myo-inositol 1-phosphate synthase is most abundant in the mammalian testis, but in which cell type the activity is located is still a matter of controversy (Eisenberg, 1967; Morris & Collins, 1971; Robinson & Fritz, 1979; . The enzyme has been purified to homogeneity from mammalian testis (Maeda & Eisenberg, 1980; Mauck et al., 1980) and yeast (Donahue & Henry, 1981) .
The reaction shown in Fig. 7 has been studied intensively for the past two decades in an attempt to elucidate the mechanism ofthis isomerization. Additional stereochemical considerations, applicable to this reaction, will be introduced as the discussion progresses. The requirement for NAD+, an oxidoreductive coenzyme, in a reaction involving no net change in composition, suggests the participation of oxidized intermediates in the process, but thedirectdemonstration ofsuchintermediates has been uniformly unsuccessful owing to their tight binding to the enzyme . Indirect experiments in which the trapping of intermediates as labelled chemically reduced products was attempted have succeeded in showing with partially purified enzyme (Chen & Eisenberg, 1975) and with homogeneous enzyme (Eisenberg & Maeda, 1985) (Kiely et al., 1978) led to the inference that the rate of cyclization of 5-ketoglucose 6-phosphate was far greater than the rate of reduction by NADH of myo-inosose-2 1-phosphate to L-myo-inositol 1-phosphate, precluding the possibility of demonstrating the Vol. 235 Fig. 7 , the , anomer of glucose 6-phosphate is the reactive species in the isomerization (Wong & Sherman, 1985) .
Besides the closure of the carbon-carbon bond, the transfer of hydrogen is the salient feature of the mechanism of Fig. 7 . Oxidation at C-5 of glucose 6-phosphate by NAD+ and reduction at C-2 of myoinosose-2 1-phosphate by NADH imply the operation of a hydrogen shuttle between substrate and coenzyme; since C-4 of reduced nicotinamide carries a pair of hydrogen atoms, a stereoselective choice presents itself.
HB of NADH is apparently transferred while HA remains uninvolved in the transfer (Byun & Jenness, 1981) . The steric constraints of ring closure between C-6 and C-I leading uniquely to the myo isomer ofinositol 1-phosphate necessitate a similar choice between the paired hydrogen atoms at C-6 of 5-ketoglucose 6-phosphate; Hs is retained in the isomerization while HR is lost to the medium (Loewus et al., 1980) . Since both reactants are chiral the paired hydrogen atoms in each are both geometrically and chemically distinct; they stand in diastereotopic relationship to each other and can be differentiated by any agent, chiral or achiral, or by any physical measurement. Chemical and physical evidence both attest to the differentiability of NADH hydrogens (Rob et al., 1984; You, 1985) . Not required for selection of the appropriate hydrogen atom, the enzyme confers absolute specificity based on chemical differences between paired atoms. In contrast, paired atoms at a prochiral centre (e.g. C-2 ofethanol, an achiral compound) are only differentiable on the basis of their geometry, requiring for their selective mobilization a chiral agent, usually an enzyme (Levy et al., 1962) . These hydrogen atoms stand in enantiotopic relationship to each other. In general, then, paired groups in achiral environments require chiral agents for differentiation; paired groups in chiral environments can be differentiated by any agent or physical measurement.
[C-6 of glucose 6-phosphate and C-4 of reduced nicotinamide of NADH have been classified as prochiral carbons because they are bound to paired hydrogen atoms and two unlike groups (Hanson, 1966) . But where at least one of the unlike groups is chiral, as in the two examples cited, the term prochiral fails to meet the definition of prochirality set out earlier (see under 'Stereochemistry'); total molecular chirality precludes local prochirality (Mislow & Siegel, 1984) . For this reason we have avoided the designation of these carbons as prochiral in the discussion of hydrogen transfer in the isomerization of glucose 6-phosphate to L-myo-inositol 1-phosphate. Individual hydrogen atoms are assigned configuration based on priority of groups bound to the particular carbon in question (Hanson, 1966) . For C-6 of glucose 6-phosphate, 0 > C-5 > H,H; each hydrogen atom in turn is given the higher priority and assigned configuration depending on the direction of ordering of bound groups. The hydrogen which is part of the clockwise sequence O,C-5,H is called HR; its partner in the anticlockwise sequence is HS. For C-4 of NADH, C-3 > C-5 > H,H; the hydrogen of the clockwise sequence C-3, C-5, H is HR and its anticlockwise partner Hs. But to avert the confusion in Fig. 7 certain to result from using the same notation as for the C-6 hydrogens, the NADH hydrogens are instead designated HA and HB, respectively (Cornforth et al., 1962) .]
The carbonyl groups of 5-ketoglucose 6-phosphate and C-4 of the nicotinamide ring of NAD+ are sites of further stereoselectivity affecting the nature of the cyclohexanehexol isomer produced. Atoms doubly bound to carbon such as carbonyl oxygen and aromatic carbon can be treated as a pair of like groups, only one of which participates in further reactions. In the ring closure at C-l and in the reduction at C-5 of 5-ketoglucose 6-phosphate, the re faces are involved (Loewus et al., 1980) ; in the transfer of hydride to C-4 of NAD+ it is the si face that receives HB (Byun & Jenness, 1981) .
[ (Posternak, 1965b) .
The faces are identified by the priority rule (Hanson, 1966) ; for 5-ketoglucose 6-phosphate the priority at C-S is 0 > C-6 > C-4; at C-1, 0 > C-2 > H. In Fig. 7 the viewer sees that the priority at C-5 is anticlockwise; the face is therefore designated si. At C-I the priority is clockwise, thus re; the faces remote from the viewer are re and si, respectively. At C4 of NAD+ the priority is C-3 > C-S > H; the near face with clockwise order is re and the remote si.] In this connection it is important to recognize the fallacy in assuming that in chemically synthesized doubly tritiated substrates, e.g. [6-3H2]glucose 6-phosphate, both atoms are equally labelled; on the contrary, owing to inherent chemical differences in the two faces of a precursor carbonyl group situated in achiral environment, it is likely that reductive processes will lead to unequal labelling to the extent of 2:1 as shown by Lemieux & Howard (1963) in the reduction of a pentodialdose with LiAl2H4. In studying the mechanism of L-myo-inositol 1-phosphate synthase, Chen & Charalampous (1967) found in the medium one-half the 3H incorporated into L-myo-inositol 1-phosphate from [6-3H2jglucose 6-phosphate and inferred from this apparent isotope effect the intermediate role of 5-ketoglucose 6-phosphate. Their inference was based on the assumption that the substrate C-6 hydrogens were at equal specific radioactivity, when in fact there could have been a 2-fold difference in specific activity. Biosynthesis and breakdown of phosphatidylinositol
The notable exception to our earlier statement that the C-6-C-l edge is the preferred site of enzymic attack on myo-inositol is the formation of phosphatidylinositol, in which the attack occurs on the C-3-C-4 edge (Fig. 8) .
The first demonstration of lipid-bound myo-inositol in mammals was made by Folch & Woolley (1942) who discovered myo-inositol in brain lipids. Phosphatidylinositol was later shown to be synthesized by a reversible stereospecific attack on C-3 of free myo-inositol by phosphatidyl-CMP (CDP-diglyceride) catalysed by a membrane-bound transferase (Figs. 1 and 8) (Agranoff et al., 1958; Paulus & Kennedy, 1960) . As shown by Ballou & Pizer (1960) in the proof of structure of phosphatidylinositol, the compound is a derivative of D-myoinositol 1-phosphate; following the rule oflowest number priority the numbering in the derivative changes to anticlockwise. The, systematic name is phosphatidyl-l-Dmyo-inositol. Contrary to published rules of nomenclature (IUPAC-IUB Commission on Biochemical Nomenclature, 1977 Nomenclature, /1978 ) no phosphoinositides of the L series are known.
[These rules have been clarified by Agranoff (1978) , who in an effort to assure that myo-inositol derivatives are numbered consistently on the axial OH side of the ring, has metamorphosed Fig. 2 into a mnemonic turtle, the head representing the axial OH at C-2 and the tail at C-S. These rules might have been more quickly adopted had they been illustrated with a symbol of speediness rather than slowness. Correct names and structures of the phosphoinositides have appeared in a recent newsletter (Nomenclature Committee of IUB and IUPAC-IUB Joint Commission on Biochemical Nomenclature, 1985) .]
Phosphatidylinositol has long been of biological interest since it was found, with phosphatidic acid but not the other phospholipids, to undergo greatly increased turnover in membranes of many tissues stimulated by a variety of agonists: a-adrenergic and muscarinic cholinergic agents, among others (Hokin, 1985) . Although the chemistry of the synthetic segment (Fig. 8) was clarified early, the process of breakdown has not been understood until recently (Fig. 1) . Notwithstanding the presence in various systems of enzymes catalysing hydrolysis of phosphatidylinositol at either phosphoryl diester linkage, it was impossible to discern which of these was of primary importance in a particular system until the introduction of Li+ as an inhibitor of myo-inositol 1 -phosphatase. As an example of the clarification resulting from the use of Li+ it is appropriate to cite the work of Hokin-Neaver- son & Sadeghian (1984) . In mouse exocrine pancreas stimulated with cholecystokinin free myo-inositol formation from phosphatidylinositol exceeded that of myoinositol 1-phosphate while under the identical conditions, except for the addition of Li+, the reverse was found. Experiments of this kind performed in many laboratories have led to the conclusion that phosphatidylinositol is broken down to diacylglycerol and myo-inositol in sequential reactions catalysed by phospholipase C and myo-inositol 1 -phosphatase. Inhibition of myo-inositol 1-phosphatase by Li+ The application of Li+ inhibition to this problem was the culmination of several stages of development beginning with the observation by Allison & Stewart (1971) that free myo-inositol levels decreased markedly in brains of Li+-treated rats, followed by the demonstration by Naccarato et al. (1974) , that mammary gland myo-inositol 1-phosphatase was specifically inhibited by Li+ in vitro. Allison (1978) then showed that brain myo-inositol 1-phosphate increased, with the decrease in myo-inositol, in Li+-treated rats. Hallcher & Sherman (1980) confirmed the inhibition of myo-inositol 1-phosphatase by Li+ in bovine brain in vitro. Finally the observation of Sherman et al. (1981) that the D enantiomer of myo-inositol 1-phosphate accumulated in these brains, and not the L enantiomer, clearly implicated phospholipase C in the breakdown of phosphatidylinositol, a dramatic illustration of the importance of stereochemistry in biological mechanisms. A linkage between the myo-inositol pathway and the pharmacological action of Li+ in treatment of brain disorders is now being sought and Li+ as a tool of the cell biologist in studies of the phosphoinositides in cellular processes is now firmly entrenched (Berridge et -al., 1982) . An explanation for the inhibitory action of Li+ must await purification of the enzyme.
[The separation of the enantiomeric myo-inositol 1-phosphates on a chromatographic scale was achieved by g.l.c. (Sherman et al., 1981) (1980) we also found no differential lethality of the lithium isotopes in mice; LD50 for 6LiCl, 7LiCl, and natural LiCl (93 % 7Li+, 7 % 6Li+) was 17.7 mequiv./kg. Their recommendation to replace inexpensive natural lithium salts with costly 7Li for therapeutic use is without merit. Non-stereospecificity of myo-inositol 1-phosphatase
The central theme of this Review has been the stereoselectivity of enzymic reactions with enantiotopic groups within the same molecule. The same considerations apply to enantiotopic groups in different molecules, i.e. enantiomers; chiral agents attack them at different rates and with enzymes the selection is usually absulute. An exception to this rule is the non-stereospecificity of the hydrolysis of enantiomeric myo-inositol 1-phosphates by specific myo-inositol 1 -phosphatase (Eisenberg, 1967; Hallcher & Sherman, 1980; Eisenberg & Parth'asarathy, 1984) ; both the D and L isomers are nearly equally active substrates for the enzyme. Because of the dissimilar geometry of these substrates it is clear that the active centre of the enzyme must be uniquely designed to recognize a subtle, but unknown, structural feature common to both isomers or to produce a common transition form during the course of the reaction. Further work is needed to explain this unusual lack of optical selectivity.
Second messengers
The stimulated turnover of phosphatidylinositol is the gross manifestation of a subtler process involving two derivatives of phosphatidylinositol: phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate (Fig. 1) . Although Ca2+ mobilization had been observed for a long time as a concomitant of stimulated phosphatidylinositol turnover in many systems (Michell et al., 1981) , it is only recently that the relationship between the two phenomena has been established. With the wealth of experimental evidence provided in the past 3 years there seems to be no doubt that receptor-mediated hydrolysis of phosphatidylinositol 4,5-bisphosphate mobilizes Ca2+ from the endoplasmic reticulum to the cytosol and stimulates protein kinase C, the result of liberation of myo-inositol trisphosphate (Streb et al., 1983; Burgess et al., 1984; Joseph et al., 1984) and diacylglycerol (Nishizuka, 1984) , respectively. Both of these compounds are generated rapidly in low concentra-tion and are quickly removed, properties required of molecules that signal cells to carry out designated functions. The active species of myo-inositol trisphosphate is known systematically as D-myo-inositol 1,4,5-trisphosphate, reflecting the configuration of the parent phosphoinositide, phosphatidyl I-D-myo-inositol 4,5-bisphosphate (Fig. 9) . A recent n.m.r. spectroscopic study by Lindon et al. (1986) confirms the myo structure of the trisphosphate and the presence only of equatorial phosphates, none of which occupy positions 2 and 3 (Fig. 9) . The chemical events linking the appearance of myoinositol trisphosphate to the release of Ca2+ remain obscure. Irvine et al. (1984a) have examined the specificity of myo-inositol trisphosphate-stimulated Ca2+ release and found that alterations in the location of the phosphate groups from the 1,4,5 positions (Fig. 9) had a markedly deleterious effect. myo-Inositol 2,4,5-trisphosphate was only one-fifth as active as the 1,4,5 isomer. The 2,4,5 isomer was isolated from brain along with the 1,4,5 isomer and is probably an artifact of the isolation procedure, since a phosphoryl group in diester linkage is subject to transphosphorylation from the 1 position of myo-inositol to the 2 position during alkaline hydrolysis of the phosphoinositide, as discussed by Posternak (1965c) . Additionally there is no evidence in animal systems for myo-inositol 2-phosphate, the penultimate hydrolytic product of myo-inositol. 2,4,5-trisphosphate, They also tested the bisphosphates and found 1/60 the activity with the 4,5 isomer and none with the 1,4 isomer. From these findings they concluded that 4,5 trans-vicinal substitution and transannular substitution preferably at C-1 are essential to Ca2+-mobilizing activity. All bis-and trisphosphates mentioned are of D configuration.
Adding to the complexity of the second messenger role of the myo-inositol polyphosphates already described is the discovery of additional water-soluble phosphates in rat organs subjected to receptor mediated muscarinic stimulation, with possible implication in Ca2+ mobilization. In parotid gland fragments Irvine et al. (1984b) have tentatively identified myo-inositol 1 ,3,4,-trisphosphate, of unknown configuration. In cerebral cortical slices Batty et al. (1985) have preliminarily identified myo-inositol 1,3,4,5-tetrakisphosphate, probably of D configuration. The early appearance of this compound after stimulation suggests a role both as second messenger and precursor of the trisphosphates. Both groups of investigators recommend caution in interpretation of their structural studies, which are based solely on chromatographic comparisons. The nature of the lipids from which these esters might be derived is unknown. An easy way to confirm the characterizations is reduction of the aldehydic intermediates produced in their degradation procedures with NaB3H4. This manoeuvre will provide sufficient label for purification of carrier-diluted putative altritol and xylitol to constant specific radioactivity and at the same time enable the determination of the configuration of altritol representing myo-inositol 1,3,4-trisphosphate but not xylitol (meso) representing myoinositol 3,4,5-trisphosphate. myo-Inositol polyphosphatases An essential requirement of second messengers is that they be rapidly destroyed after performing their signal function in order to restore the system to the basal state in preparation for a new stimulus. In the liver, in which the most recent work has been done (Storey et al., 1984; Seyfred et al., 1984; Joseph & Williams, 1985) this function is served by specific monoesterases that sequentially convert myo-inositol 1,4,5-trisphosphate to the 1 ,4-bisphosphate and ultimately to myo-inositol via the 4-phosphate (Storey et al., 1984; Sherman et al., 1985) or the 1-phosphate (Fig. 1) . There is no information on configurational specificity of these enzymes except with respect to myo-inositol 1-phosphate, as discussed earlier.
In the liver the trisphosphatase appears to be confined to the plasma membrane and the other phosphatases to the cytosol, a result that makes it difficult to visualize the movement ofmyo-inositol trisphosphate from the plasma membrane where it is generated to the endoplasmic reticulum where it stimulates Ca2+ release, if it is destroyed in the plasma membrane. Seyfred et al. (1984) suggest that the activity may also be in the cytosol but is kept inhibited by polyamines during Ca2+ release. Connolly et al. (1985) report a soluble trisphosphatase in platelets which is inhibited by Ca2+, but do not suggest how Ca2+ inhibition of the enzyme is compatible with restoration of the system to the basal state. Further studies will undoubtedly resolve these seeming contradictions.
Conclusion
We have attempted to present in this Review what we hope is a simplified, straightforward, and adequately illustrated explanation ofconfiguration and conformation and their part in the stereochemistry of myo-inositol, its phosphoric esters, and the inositol phospholipids. We have applied these principles to biosynthetic and catabolic processes. The correct nomenclature should follow from our development of these subjects. Our further hope is that workers in this field, both veteran and newly attracted, pause to digest this information in an effort to rid this important area of biochemistry of the confusion and error that, with time, have gathered around it.
